Citadel Advisors’s Aphria Inc. Common Shares APHA Stock Holding History

Citadel Advisors’s Portfolio APHA Stock Details APHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,453	Closed	-$945K	–	14965
2021 Q1	$945K	Buy	+51,453	New	+$834K	﹤0.01%	8269
2020 Q4	–	Sell	-180,165	Closed	-$1.12M	–	11797
2020 Q3	$798K	Sell	180,165 -374,299	-68%	-$1.75M	﹤0.01%	6429
2020 Q2	$2.38M	Buy	+554,464	New	+$2.13M	﹤0.01%	4268
2020 Q1	–	Sell	-13,386	Closed	-$53.4K	–	10470
2019 Q4	$70K	Buy	+13,386	New	+$65.7K	﹤0.01%	8673
2019 Q2	–	Sell	-256,418	Closed	-$1.94M	–	10160
2019 Q1	$2.39M	Buy	256,418 +200,707	+360%	+$1.76M	﹤0.01%	4163
2018 Q4	$317K	Buy	+55,711	New	+$439K	﹤0.01%	7167

Citadel Advisors's APHA Position: Q2 2021 in Review

Citadel Advisors sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 51,453 shares — an estimated $945K sold.

Citadel Advisors first reported a position in APHA in Q4 2018 and held it in 6 quarters. The position peaked at $2.39M in Q1 2019. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

Citadel Advisors reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
Citadel Advisors sold 51,453 Aphria Inc. Common Shares shares in Q2 2021, an estimated $945K.
Citadel Advisors first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 6 quarters.
Citadel Advisors's Aphria Inc. Common Shares position peaked at $2.39M in Q1 2019.
0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.